The mean platelet volume in subjects with impaired fasting glucose

By Coban Erkan   Bostan F.   Ozdogan M.  

Platelets, Vol. 17, Iss. 1, 2006-02 ,pp. : 67-69

Informa Healthcare

Access to resources Recommend Favorite

Platelet activation in subjects with impaired glucose tolerance

By Coban Erkan   Kucuktag S.   Basyigit S.  

Platelets, Vol. 18, Iss. 8, 2007-12 ,pp. : 591-594

Informa Healthcare

Access to resources Recommend Favorite

Response to Chiasson et al.: Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

By Sawicki P.   Kaiser T.  

Diabetologia, Vol. 47, Iss. 6, 2004-06 ,pp. : 976-977

Springer Publishing Company

Access to resources Recommend Favorite

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

By Chiasson J.-L.   Josse R.   Gomis R.   Hanefeld M.   Karasik A.   Laakso M.  

Diabetologia, Vol. 47, Iss. 6, 2004-06 ,pp. : 969-975

Springer Publishing Company

Access to resources Recommend Favorite

The role of obesity and cardiovascular fitness in the impaired glucose tolerance of aging

By Colman E.   Katzel L.L.   Sorkin J.   Coon P.J.   Engelhardt S.   Rogus E.   Goldberg A.P.  

Experimental Gerontology, Vol. 30, Iss. 6, 1995-11 ,pp. : 571-580

Elsevier

Access to resources Recommend Favorite